Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.09 USD | -5.43% | +3.22% | +20.59% |
May. 15 | Wells Fargo Starts WAVE Life Sciences With Overweight Rating, $11 Price Target | MT |
May. 09 | Transcript : Wave Life Sciences Ltd., Q1 2024 Earnings Call, May 09, 2024 |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
WAVE LIFE SCIENCES LTD. | Bio Therapeutic Drugs | -5.43% | +3.22% | +20.59% | +64.15% | -75.57% | 789M |
- Stock Market
- Equities
- WVE Stock
- Charts Wave Life Sciences Ltd.
- Relative Strength Chart